microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance

A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the f...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation Vol. 132; no. 10; pp. 1 - 16
Main Authors: Fujiwara, Mai, Raheja, Radhika, Garo, Lucien P., Ajay, Amrendra K., Kadowaki-Saga, Ryoko, Karandikar, Sukrut H., Gabriely, Galina, Krishnan, Rajesh, Beynon, Vanessa, Paul, Anu, Patel, Amee, Saxena, Shrishti, Hu, Dan, Healy, Brian C., Chitnis, Tanuja, Gandhi, Roopali, Weiner, Howard L., Murugaiyan, Gopal
Format: Journal Article
Language:English
Published: United States American Society for Clinical Investigation 16.05.2022
Subjects:
ISSN:1558-8238, 0021-9738, 1558-8238
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR-92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR-92a mediated EAE susceptibility in a T cell-intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in CD4+ T cells from patients with MS, and miR-92a silencing in patients' T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.
AbstractList A disequilibrium between immunosuppressive Tregs and inflammatory IL-17- producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR- 92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR92a mediated EAE susceptibility in a T cell-intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in [CD4.sup.+] T cells from patients with MS, and miR-92a silencing in patients' T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR-92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR-92a mediated EAE susceptibility in a T cell-intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in CD4+ T cells from patients with MS, and miR-92a silencing in patients' T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR-92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR-92a mediated EAE susceptibility in a T cell-intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in CD4+ T cells from patients with MS, and miR-92a silencing in patients' T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17–producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR-92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR-92a mediated EAE susceptibility in a T cell–intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in CD4+ T cells from patients with MS, and miR-92a silencing in patients’ T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis (MS). However, the molecular mechanisms underlying the Treg and Th17 imbalance in CNS autoimmunity remain largely unclear. Identifying the factors that drive this imbalance is of high clinical interest. Here, we report a major disease-promoting role for microRNA-92a (miR-92a) in CNS autoimmunity. miR-92a was elevated in experimental autoimmune encephalomyelitis (EAE), and its loss attenuated EAE. Mechanistically, miR92a mediated EAE susceptibility in a T cell-intrinsic manner by restricting Treg induction and suppressive capacity, while supporting Th17 responses, by directly repressing the transcription factor Foxo1. Although miR-92a did not directly alter Th1 differentiation, it appeared to indirectly promote Th1 cells by inhibiting Treg responses. Correspondingly, miR-92a inhibitor therapy ameliorated EAE by concomitantly boosting Treg responses and dampening inflammatory T cell responses. Analogous to our findings in mice, miR-92a was elevated in CD4+ T cells from patients with MS, and miR-92a silencing in patients' T cells promoted Treg development but limited Th17 differentiation. Together, our results demonstrate that miR-92a drives CNS autoimmunity by sustaining the Treg/Th17 imbalance and implicate miR-92a as a potential therapeutic target for MS.
Audience Academic
Author Gabriely, Galina
Gandhi, Roopali
Fujiwara, Mai
Beynon, Vanessa
Chitnis, Tanuja
Murugaiyan, Gopal
Garo, Lucien P.
Ajay, Amrendra K.
Karandikar, Sukrut H.
Raheja, Radhika
Hu, Dan
Krishnan, Rajesh
Weiner, Howard L.
Patel, Amee
Saxena, Shrishti
Healy, Brian C.
Paul, Anu
Kadowaki-Saga, Ryoko
AuthorAffiliation 3 Renal Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
1 Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
2 Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
AuthorAffiliation_xml – name: 2 Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
– name: 3 Renal Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
– name: 1 Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
Author_xml – sequence: 1
  givenname: Mai
  orcidid: 0000-0001-5540-182X
  surname: Fujiwara
  fullname: Fujiwara, Mai
– sequence: 2
  givenname: Radhika
  surname: Raheja
  fullname: Raheja, Radhika
– sequence: 3
  givenname: Lucien P.
  surname: Garo
  fullname: Garo, Lucien P.
– sequence: 4
  givenname: Amrendra K.
  orcidid: 0000-0003-2790-5726
  surname: Ajay
  fullname: Ajay, Amrendra K.
– sequence: 5
  givenname: Ryoko
  surname: Kadowaki-Saga
  fullname: Kadowaki-Saga, Ryoko
– sequence: 6
  givenname: Sukrut H.
  surname: Karandikar
  fullname: Karandikar, Sukrut H.
– sequence: 7
  givenname: Galina
  surname: Gabriely
  fullname: Gabriely, Galina
– sequence: 8
  givenname: Rajesh
  surname: Krishnan
  fullname: Krishnan, Rajesh
– sequence: 9
  givenname: Vanessa
  surname: Beynon
  fullname: Beynon, Vanessa
– sequence: 10
  givenname: Anu
  surname: Paul
  fullname: Paul, Anu
– sequence: 11
  givenname: Amee
  surname: Patel
  fullname: Patel, Amee
– sequence: 12
  givenname: Shrishti
  orcidid: 0000-0003-3429-5671
  surname: Saxena
  fullname: Saxena, Shrishti
– sequence: 13
  givenname: Dan
  surname: Hu
  fullname: Hu, Dan
– sequence: 14
  givenname: Brian C.
  surname: Healy
  fullname: Healy, Brian C.
– sequence: 15
  givenname: Tanuja
  surname: Chitnis
  fullname: Chitnis, Tanuja
– sequence: 16
  givenname: Roopali
  surname: Gandhi
  fullname: Gandhi, Roopali
– sequence: 17
  givenname: Howard L.
  surname: Weiner
  fullname: Weiner, Howard L.
– sequence: 18
  givenname: Gopal
  orcidid: 0000-0003-0439-1363
  surname: Murugaiyan
  fullname: Murugaiyan, Gopal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35298438$$D View this record in MEDLINE/PubMed
BookMark eNqNk99v2yAQx62p09pme9g_MFmaNG0PbgFjG79MiqL9yFS1UtvtFQEGh8iGDPC0_PfDS5vFWx4mHoDjc9-Du-M8OTHWyCR5CcEFhBW6_LJYwqIo6_xJchYXJCMoJycH69Pk3Ps1ABDjAj9LTvMC1QTn5CwRvRbO3l7PsxqxdONsb4P06eL6LmVDsLrvB6PDNuXbtLfN0LGgTZuGlUydbMetdduUmSbVRnWs73eG-1TIrks565gR8nnyVLHOyxcP8yz5-vHD_eJzdnXzabmYX2WirPKQoRywIod5gTkuc4QAARBKBXjNQU0UKopaCFEL0HAlCFG45AI1kCjeCMkIyWfJcqfbWLamG6d75rbUMk1_G6xrKXNBi05SRepG8EpIBQVGktSYQFTE-KJRRcNh1Hq_09oMvJcxgAmOdRPR6YnRK9raH7SGoMxxFQXePgg4-32QPtBe-zErzEg7eIpKDGNBCCkj-vovdG0HZ2KqIlXBCpICHFAtiw-I6bYxrhhF6bwCmIAKx1LPkuwI1Uoj4yVj1ygdzRP-4ggfRyNjZxx1eDdxiEyQP0PLBu_p8u72_9mbb1P2zQG7kqwLK2-7IWhr_BR8dViZfUkeezoClzsgNrb3TioqdGCjTnya7igEdPw1dP9r_txz7_Eo-i_7C_AmElQ
CitedBy_id crossref_primary_10_1002_adtp_202500124
crossref_primary_10_7759_cureus_86988
crossref_primary_10_1093_ijnp_pyae013
crossref_primary_10_1007_s10142_023_01028_w
crossref_primary_10_1096_fj_202302028R
crossref_primary_10_1111_jpi_13009
crossref_primary_10_1111_cns_14161
crossref_primary_10_1080_14728222_2023_2236301
crossref_primary_10_1002_adma_202210262
crossref_primary_10_1186_s12967_024_05450_x
crossref_primary_10_3390_biomedicines12112507
crossref_primary_10_1126_scitranslmed_adp5802
crossref_primary_10_3389_fnmol_2023_1199313
crossref_primary_10_1002_eji_202250228
crossref_primary_10_3389_fimmu_2023_1320305
crossref_primary_10_1016_j_lfs_2025_123844
crossref_primary_10_1016_j_molmed_2025_03_006
crossref_primary_10_1161_CIRCRESAHA_123_322835
crossref_primary_10_1002_anbr_202300068
crossref_primary_10_1016_j_it_2022_09_003
crossref_primary_10_1016_j_jbc_2025_110560
crossref_primary_10_3389_fimmu_2025_1584001
crossref_primary_10_1016_j_envpol_2023_122416
crossref_primary_10_3389_fnmol_2023_1173212
crossref_primary_10_1111_brv_13048
crossref_primary_10_2147_DDDT_S510620
crossref_primary_10_3389_fimmu_2023_1257192
Cites_doi 10.1124/pr.120.019554
10.1093/rheumatology/kes120
10.1074/jbc.M112.445429
10.1038/cdd.2013.125
10.1038/nature11581
10.1038/nm1564
10.1055/s-0036-1579739
10.1158/0008-5472.CAN-09-4104
10.1038/nature09447
10.1016/j.cell.2008.05.009
10.1016/j.celrep.2012.02.007
10.1007/s10753-018-0887-3
10.1038/ni.2031
10.1093/brain/awr200
10.1111/tan.12874
10.1056/NEJMoa1209026
10.1016/S1474-4422(17)30470-2
10.1038/nm.2389
10.1038/ni.1613
10.1084/jem.20082584
10.1074/jbc.M114.550723
10.1111/j.1365-2249.2010.04143.x
10.1177/1352458512473189
10.1073/pnas.1114325109
10.4049/jimmunol.1403243
10.4049/jimmunol.1003952
10.4049/jimmunol.1500849
10.3892/ijmm.2013.1287
10.1111/imr.12172
10.1016/j.clim.2011.01.013
10.1002/eji.201344280
10.1016/j.immuni.2008.05.007
10.3389/fgene.2012.00311
10.1016/j.immuni.2010.12.002
10.1038/ni.2027
10.4049/jimmunol.1203567
10.1016/j.omtn.2017.06.005
10.1016/j.immuni.2016.06.022
10.1007/s12031-014-0476-3
10.1586/14737175.9.3.319
10.1371/journal.pone.0021386
10.1084/jem.20031579
10.1038/nri.2016.40
10.1016/j.immuni.2013.10.016
10.1016/j.celrep.2016.06.101
10.1038/emm.2017.313
10.1016/j.cell.2010.02.021
10.1001/jamaneurol.2016.5197
10.4161/rna.25557
10.3748/wjg.v22.i7.2195
10.1038/nature11984
10.1038/ni1539
10.1016/j.jneuroim.2013.06.007
10.1016/S1474-4422(09)70021-3
10.1038/ni1497
10.1001/jama.2020.26858
10.15252/embr.201541905
10.1089/nat.2020.0871
10.1111/imm.13178
10.1016/j.immuni.2016.05.015
10.1038/nature04754
10.1038/ni.1698
10.3390/ijms151120266
10.1212/NXI.0000000000000267
10.1186/ar4430
10.3389/fendo.2020.00009
10.1073/pnas.94.2.599
10.1016/j.cell.2006.07.035
10.1007/s00415-016-8128-x
10.1038/ng.3321
10.1002/art.24499
10.1172/JCI74347
10.1038/ncomms8096
10.1016/j.biopha.2018.09.037
10.1016/S0092-8674(01)00616-X
10.1038/nature06783
10.1084/jem.20030152
10.1038/ni.1884
10.1111/j.1365-2567.2007.02690.x
10.1261/rna.5248604
10.4049/jimmunol.0900747
10.1002/ana.21748
10.1016/j.cell.2012.09.016
10.1158/0008-5472.CAN-18-2659
10.1073/pnas.0900408106
10.1016/j.immuni.2010.09.009
10.1016/j.clim.2016.09.008
10.1038/nature04753
10.1182/blood-2011-05-355644
10.1016/j.jaut.2008.04.017
10.1038/ni.1798
10.1155/2016/7089137
10.1007/s10067-010-1510-7
ContentType Journal Article
Copyright COPYRIGHT 2022 American Society for Clinical Investigation
Copyright American Society for Clinical Investigation May 2022
2022 Fujiwara et al. 2022 Fujiwara et al.
Copyright_xml – notice: COPYRIGHT 2022 American Society for Clinical Investigation
– notice: Copyright American Society for Clinical Investigation May 2022
– notice: 2022 Fujiwara et al. 2022 Fujiwara et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7RV
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
S0X
7X8
5PM
DOA
DOI 10.1172/JCI155693
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Biological Science Collection
eLibrary (ProQuest)
ProQuest Central (New) (NC LIVE)
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Biological Science Database (NC LIVE)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic


MEDLINE
ProQuest Central Student
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
EndPage 16
ExternalDocumentID oai_doaj_org_article_f89dcb7cef1c42e89481250a5cdf5db1
PMC9106347
A704807482
35298438
10_1172_JCI155693
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA267479
– fundername: NIAID NIH HHS
  grantid: R01 AI127853
– fundername: NIAID NIH HHS
  grantid: R21 AI174047
– fundername: NIAID NIH HHS
  grantid: R21 AI175890
– fundername: NIAID NIH HHS
  grantid: R01 AI151953
– fundername: ;
  grantid: R01CA267479
– fundername: ;
  grantid: RG-1907-34560
– fundername: National Institutes of Health
  grantid: R01AI151953,R01AI127853
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
AAYXX
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
ADPDF
AEAQA
AENEX
AFCHL
AFFHD
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
EMB
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88A
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c673t-230a531354b4632208011ef0b9b098f2559ccc9c0dbfc88f46bc2d18fbdcea883
IEDL.DBID 7RV
ISICitedReferencesCount 32
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000805108300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1558-8238
0021-9738
IngestDate Mon Nov 10 04:31:20 EST 2025
Thu Nov 27 06:11:16 EST 2025
Thu Oct 02 06:21:03 EDT 2025
Tue Oct 07 05:13:29 EDT 2025
Sat Nov 29 13:18:05 EST 2025
Sat Nov 29 11:43:40 EST 2025
Sat Nov 29 10:08:03 EST 2025
Wed Nov 26 09:57:19 EST 2025
Wed Nov 26 09:31:05 EST 2025
Thu May 22 21:03:58 EDT 2025
Mon Jul 21 06:04:40 EDT 2025
Tue Nov 18 21:09:40 EST 2025
Sat Nov 29 01:34:38 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Autoimmunity
Multiple sclerosis
Inflammation
Autoimmune diseases
T cells
Language English
License http://creativecommons.org/licenses/by/4.0
This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c673t-230a531354b4632208011ef0b9b098f2559ccc9c0dbfc88f46bc2d18fbdcea883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Authorship note: MF and RR contributed equally to this work.
ORCID 0000-0001-5540-182X
0000-0003-2790-5726
0000-0003-3429-5671
0000-0003-0439-1363
OpenAccessLink https://doaj.org/article/f89dcb7cef1c42e89481250a5cdf5db1
PMID 35298438
PQID 2671718506
PQPubID 42166
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_f89dcb7cef1c42e89481250a5cdf5db1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9106347
proquest_miscellaneous_2641001886
proquest_journals_2671718506
gale_infotracmisc_A704807482
gale_infotracgeneralonefile_A704807482
gale_infotracacademiconefile_A704807482
gale_incontextgauss_ISR_A704807482
gale_incontextgauss_IOV_A704807482
gale_healthsolutions_A704807482
pubmed_primary_35298438
crossref_citationtrail_10_1172_JCI155693
crossref_primary_10_1172_JCI155693
PublicationCentury 2000
PublicationDate 2022-05-16
PublicationDateYYYYMMDD 2022-05-16
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-16
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Ann Arbor
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2022
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B64
B21
B65
B22
B66
B23
B67
B24
B68
B25
B69
B26
B27
B28
B29
Ahmed Hassan (B76) 2020; 13
Gong (B84) 2016; 2016
B70
B71
B72
B73
B30
B74
B31
B75
B33
B77
B34
B78
B35
B79
B36
B37
B38
B39
B1
B2
B3
B4
B5
B6
B7
Shidal (B93) 2019; 79
B8
B9
B80
B81
B82
B83
B40
B41
B85
B42
B86
B43
B87
B44
B88
B45
B89
B46
B47
B48
B49
Mycko (B62) 2012; 109
Noorbakhsh (B32) 2011; 134
B90
B91
B92
B50
B94
B51
B95
B52
B53
B10
B54
B11
B55
B12
B56
B13
B57
B14
B58
B15
B59
B16
B17
B18
B19
B60
B61
B63
References_xml – ident: B86
  doi: 10.1124/pr.120.019554
– ident: B75
  doi: 10.1093/rheumatology/kes120
– ident: B94
  doi: 10.1074/jbc.M112.445429
– ident: B64
  doi: 10.1038/cdd.2013.125
– ident: B45
  doi: 10.1038/nature11581
– ident: B6
  doi: 10.1038/nm1564
– ident: B1
  doi: 10.1055/s-0036-1579739
– ident: B95
  doi: 10.1158/0008-5472.CAN-09-4104
– ident: B20
  doi: 10.1038/nature09447
– ident: B52
  doi: 10.1016/j.cell.2008.05.009
– ident: B54
  doi: 10.1016/j.celrep.2012.02.007
– ident: B68
  doi: 10.1007/s10753-018-0887-3
– volume: 13
  start-page: 147
  issue: 2
  year: 2020
  ident: B76
  article-title: Potential role of plasma miR-21 and miR-92a in distinguishing between irritable bowel syndrome, ulcerative colitis, and colorectal cancer
  publication-title: Gastroenterol Hepatol Bed Bench
– ident: B22
  doi: 10.1038/ni.2031
– volume: 134
  start-page: 2703
  issue: pt 9
  year: 2011
  ident: B32
  article-title: Impaired neurosteroid synthesis in multiple sclerosis
  publication-title: Brain
  doi: 10.1093/brain/awr200
– ident: B74
  doi: 10.1111/tan.12874
– ident: B55
  doi: 10.1056/NEJMoa1209026
– ident: B34
  doi: 10.1016/S1474-4422(17)30470-2
– ident: B9
  doi: 10.1038/nm.2389
– ident: B57
  doi: 10.1038/ni.1613
– ident: B18
  doi: 10.1084/jem.20082584
– ident: B67
  doi: 10.1074/jbc.M114.550723
– ident: B24
  doi: 10.1111/j.1365-2249.2010.04143.x
– ident: B37
  doi: 10.1177/1352458512473189
– volume: 109
  start-page: E1248
  issue: 20
  year: 2012
  ident: B62
  article-title: MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1114325109
– ident: B13
  doi: 10.4049/jimmunol.1403243
– ident: B27
  doi: 10.4049/jimmunol.1003952
– ident: B43
  doi: 10.4049/jimmunol.1500849
– ident: B77
  doi: 10.3892/ijmm.2013.1287
– ident: B51
  doi: 10.1111/imr.12172
– ident: B83
  doi: 10.1016/j.clim.2011.01.013
– ident: B81
  doi: 10.1002/eji.201344280
– ident: B48
  doi: 10.1016/j.immuni.2008.05.007
– ident: B31
  doi: 10.3389/fgene.2012.00311
– ident: B42
  doi: 10.1016/j.immuni.2010.12.002
– ident: B21
  doi: 10.1038/ni.2027
– ident: B65
  doi: 10.4049/jimmunol.1203567
– ident: B87
  doi: 10.1016/j.omtn.2017.06.005
– ident: B61
  doi: 10.1016/j.immuni.2016.06.022
– ident: B63
  doi: 10.1007/s12031-014-0476-3
– ident: B73
  doi: 10.1586/14737175.9.3.319
– ident: B5
  doi: 10.1371/journal.pone.0021386
– ident: B8
  doi: 10.1084/jem.20031579
– ident: B25
  doi: 10.1038/nri.2016.40
– ident: B50
  doi: 10.1016/j.immuni.2013.10.016
– ident: B92
  doi: 10.1016/j.celrep.2016.06.101
– ident: B40
  doi: 10.1038/emm.2017.313
– ident: B2
  doi: 10.1016/j.cell.2010.02.021
– ident: B35
  doi: 10.1001/jamaneurol.2016.5197
– ident: B90
  doi: 10.4161/rna.25557
– ident: B82
  doi: 10.3748/wjg.v22.i7.2195
– ident: B46
  doi: 10.1038/nature11984
– ident: B17
  doi: 10.1038/ni1539
– ident: B3
  doi: 10.1016/j.jneuroim.2013.06.007
– ident: B72
  doi: 10.1016/S1474-4422(09)70021-3
– ident: B58
  doi: 10.1038/ni1497
– ident: B70
  doi: 10.1001/jama.2020.26858
– ident: B10
  doi: 10.15252/embr.201541905
– ident: B89
  doi: 10.1089/nat.2020.0871
– ident: B41
  doi: 10.1111/imm.13178
– ident: B26
  doi: 10.1016/j.immuni.2016.05.015
– ident: B14
  doi: 10.1038/nature04754
– ident: B19
  doi: 10.1038/ni.1698
– ident: B69
  doi: 10.3390/ijms151120266
– ident: B33
  doi: 10.1212/NXI.0000000000000267
– ident: B79
  doi: 10.1186/ar4430
– ident: B91
  doi: 10.3389/fendo.2020.00009
– ident: B23
  doi: 10.1073/pnas.94.2.599
– ident: B16
  doi: 10.1016/j.cell.2006.07.035
– ident: B71
  doi: 10.1007/s00415-016-8128-x
– ident: B36
  doi: 10.1038/ng.3321
– ident: B78
  doi: 10.1002/art.24499
– ident: B28
  doi: 10.1172/JCI74347
– ident: B59
  doi: 10.1038/ncomms8096
– ident: B80
  doi: 10.1016/j.biopha.2018.09.037
– ident: B30
  doi: 10.1016/S0092-8674(01)00616-X
– ident: B56
  doi: 10.1038/nature06783
– ident: B88
– ident: B4
  doi: 10.1084/jem.20030152
– ident: B44
  doi: 10.1038/ni.1884
– ident: B7
  doi: 10.1111/j.1365-2567.2007.02690.x
– ident: B47
  doi: 10.1261/rna.5248604
– ident: B53
  doi: 10.4049/jimmunol.0900747
– ident: B12
  doi: 10.1002/ana.21748
– ident: B39
  doi: 10.1016/j.cell.2012.09.016
– volume: 79
  start-page: 3622
  issue: 14
  year: 2019
  ident: B93
  article-title: MicroRNA-92 expression in CD133+ melanoma stem cells regulates immunosuppression in the tumor microenvironment via integrin-dependent activation of TGFβ
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-2659
– ident: B49
  doi: 10.1073/pnas.0900408106
– ident: B38
  doi: 10.1016/j.immuni.2010.09.009
– ident: B60
  doi: 10.1016/j.clim.2016.09.008
– ident: B15
  doi: 10.1038/nature04753
– ident: B66
  doi: 10.1182/blood-2011-05-355644
– ident: B11
  doi: 10.1016/j.jaut.2008.04.017
– ident: B29
  doi: 10.1038/ni.1798
– volume: 2016
  year: 2016
  ident: B84
  article-title: The Th17/Treg immune imbalance in ulcerative colitis disease in a chinese han population
  publication-title: Mediators Inflamm
  doi: 10.1155/2016/7089137
– ident: B85
  doi: 10.1007/s10067-010-1510-7
SSID ssj0014454
Score 2.5358648
Snippet A disequilibrium between immunosuppressive Tregs and inflammatory IL-17-producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis...
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17- producing Th17 cells is a hallmark of autoimmune diseases, including multiple...
A disequilibrium between immunosuppressive Tregs and inflammatory IL-17–producing Th17 cells is a hallmark of autoimmune diseases, including multiple sclerosis...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1
SubjectTerms Animals
Autoimmune diseases
Autoimmunity
Biomedical research
CD4 antigen
Cell Differentiation
Cellular control mechanisms
Cytokines
Development and progression
Disease
Encephalomyelitis
Encephalomyelitis, Autoimmune, Experimental - genetics
Encephalomyelitis, Autoimmune, Experimental - immunology
Experimental allergic encephalomyelitis
FOXO1 protein
Gene expression
Genetic aspects
Health aspects
Helper cells
Humans
Inflammation
Interleukin 17
Lymphocytes
Lymphocytes T
Mice
Mice, Inbred C57BL
MicroRNA
MicroRNAs
MicroRNAs - genetics
miRNA
Molecular modelling
Multiple sclerosis
Multiple Sclerosis - genetics
Multiple Sclerosis - immunology
Pathogenesis
Patients
T cells
T-Lymphocytes, Regulatory
Th1 Cells
Th17 Cells
Therapeutic targets
Transcription factors
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA5yiPgi_rZ6ahRRX8pt07RNH9fFwxNc5e6UeyvJJNlbcNtj2xX2v3eSZssWD_TBfWy-hXYyk5lpZ74h5I3QLElNLmOVsizm0qhYMS5jjfltArnSCWg_bKKYz8XFRfltb9SXqwnr6YF7wR1ZUWpQBRibAGdGOHYRdNsyA20zrXzig1HPLpkK3w84z3jgEUIPffR5doJ-My_TkffxJP1_HsV7vmhcJ7nneI7vkjshYqTT_k7vkRumvk9ufQnfxB8QWLmautP5NC6ZpFe-vM60dDY_o3LTNUvfANJtqdrSVaP9tK56QTHuo-t-Dn2z3lJZa4q6huqx6i-cU_dKnypX-QjmIfl-_PF89ikOoxNiyIu0izGxkGhdacYVz9FmUUJJYuxElWpSCuvyCAAoYaKVBSEszxUwnQir8GGlEOkjclA3tXlCaJJaZkCA5ExzPN-EKZnGH2eykFLpiLzfibSCwCvuxlv8rHx-UbBqkH5EXg_Qq55M4zrQB7cvA8DxX_sLqBVV0Irqb1oRkZduV6u-mXSw4mpa-B56Lhjei0c4DozaFdks5KZtq5OvP_4BdHY6Ar0LINvgg4MMjQ0oPsetNUK-HSEXPbP4dcDDERBNHsbLO2WtwpHTVizHzDxxBIQReTUsu3-6MrraNBuH4Y5zSwjEPO51e5AzRuKl4KmISDHS-tFGjFfq5aUnJMeQM0958fR_7Nwzcpu5DhNHkJsfkoNuvTHPyU341S3b9Qtv5b8BZ95ZdQ
  priority: 102
  providerName: Directory of Open Access Journals
Title microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
URI https://www.ncbi.nlm.nih.gov/pubmed/35298438
https://www.proquest.com/docview/2671718506
https://www.proquest.com/docview/2641001886
https://pubmed.ncbi.nlm.nih.gov/PMC9106347
https://doaj.org/article/f89dcb7cef1c42e89481250a5cdf5db1
Volume 132
WOSCitedRecordID wos000805108300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: DOA
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: 7RV
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Biological Science
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: M7P
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: BENPR
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 1558-8238
  databaseCode: 7X7
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZgQ4gX7pfCKAYh2Eu02nFj5wl11SaGRKm6MfUt8i2lEk1K0yL13-PjuGERE0IiD3mIv0iJfXwu9vF3EHorDCWxTWSkYtqPmLQqUpTJyLj4luhEGaKNLzbBRyMxnabjsOBWhbTKnU70itqUGtbIj2jiAg8C_Goflj8iqBoFu6uhhMZNtE_Adjt55pPLZheBsX5gYSZRymMRmIWczT76NDxzljRJ45Y98rT9fyrnK9apnTl5xRSd3vvfn7iP7gYnFA9qqXmAbtjiIbr9OWyzP0J6AWl6k9EgSqnES5-xZys8HJ1juVmXc3-mZL3FaosXpfEFwIoZdq4kXtWl7cvVFsvCYCe-TuIW9YMLDLsEWEEypbaP0dfTk4vhxyhUY4h0wuN15GIV6SZs3GeKJU4NOFeTEJv3VKp6qcghNNFap7pnVK6FyFmiNDVE5Mr1lhQifoL2irKwzxAmcU6tFloyaphTmcKm1LiLUcmlVKaDDndjkulAVQ4VM75nPmThNGuGr4PeNNBlzc9xHegYBrYBAKW2f1CuZlmYoVkuUqMV1zYnmlErgMbG-Yeyr03eN4p00CsQi6w-n9oohmzA_bF8Jqj7Fo8AWo0C8nZmclNV2dmXy38AnU9aoPcBlJfux7UMZyVc9wFdVwv5roWc1WTl1wEPWkCnRXS7eSexWdBiVfZbXDvoddMMb0JmXmHLDWAY0HgJ4TBP68nR9LNz7lPBYtFBvDVtWgPRbinm3zzHufNik5jx53__rBfoDoXjKMCmmxygvfVqY1-iW_rnel6tul4ZwH3K_V100f7xyWg86fqVly7k-Y5_Ae_GbZI
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgoAL70eg0AXxuliN1xt7fUAoBKqGtgG1AeVm9uUQidghTkD5U_xGZtaOqUWFuPRAbvF-iez1PO2Zbwh5IgzzAxtKTwWs43FplacYl56B_NbXoTK-Nm7YRDQYiNEo_rBBfq57YbCscm0TnaE2ucZn5DsshMTDR361V7NvHk6Nwrer6xEapVjs29UPSNmKl_03cH-fMrb7dtjb86qpAp4Oo2DhQcwtQfCCDlc8BHGGkMn3bdpWsWrHIsUQW2sd67ZRqRYi5aHSzPgiVUZbKUQA_3uOnAc7HmEJWTSqEzzITToV67PvxVEgKiYjiBF23vX64LnDOGj4Pzcm4E9ncMIbNis1T7i-3av_26ZdI1eqIJt2S624TjZsdoNcPKzKCG4SPcUyxKNB14uZpDNXkWgL2hscU7lc5BPXM7NYUbWi09y4AWfZmEKoTOd2jF_z-YrKzFBQT9CoaXlgSPEtCFVYLKrtLfLxTC7xNtnM8szeJdQPUma10JIzw8ElCBszAx_OZCSlMi3yYi0Dia6o2HEiyNfEpWQRS2pxaZHHNXRW8o-cBnqNglQDkDLcHcjn46SyQEkqYqNVpG3qa86sQJoeiH9lR5u0Y5TfItsohknZf1sbvqQbOdoBLhici0MgbUiGdUljuSyKpP_-0z-Ajo8aoOcVKM3hwrWsekFg-5COrIF81kCOSzL204BbDSBYSd1cXmtIUlnpIvmtHi3yqF7GX2LlYWbzJWI40pQJAZg7pTLW-wzJSyx4IFokaqhp40Y0V7LJF8fhDlF6GPDo3t9Pa5tc2hseHiQH_cH-fXKZYesNMgeHW2RzMV_aB-SC_r6YFPOHzhBR8vmslfgXHBfFLg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9NAFB6VFlVc2JdAoQNiu1iJxxN7fEAoTRsRCiZqC-rNzOYQidghTkD5a_w63rMdU4sKcemB3Oz5HNnjt3refI-Qp8Iw17O-dJTHug6XVjmKcekYyG9d7SvjalM0mwiiSJyehqMN8nO9FwbLKtc2sTDUJtP4jbzNfEg8XORXaydVWcRof_B69s3BDlK40rpup1GKyKFd_YD0LX813Id3_YyxwcFJ_41TdRhwtB94CwfibwlC6HW54j6INoRPrmuTjgpVJxQJhtta61B3jEq0EAn3lWbGFYky2kohPPjfS2QrgCADtGtr7yAaHdVrGJx3Kw5o1wkDT1S8RhAxtN_2h-DH_dBreMOiacCfruGMb2zWbZ5xhINr__MUXidXq_Cb9kp9uUE2bHqTbL-vCgxuET3FAsWjqOeETNJZUatoc9qPjqlcLrJJsZtmsaJqRaeZKVqfpWMKQTSd2zEeZvMVlamhoLiga9PyxAnF9RGqsIxU29vk44U84h2ymWapvUeo6yXMaqElZ4aDsxA2ZAZ-nMlASmVa5OVaHmJdkbRjr5CvcZGsBSyuRadFntTQWclMch5oD4WqBiCZeHEim4_jyjbFiQiNVoG2ias5swIJfCAyll1tkq5RbovsokjG5c7c2iTGvaAgJOCCwb0UCCQUSVGuxnKZ5_Hww6d_AB0fNUAvKlCSwYNrWe0SgelDorIG8nkDOS5p2s8D7jSAYD91c3itLXFlv_P4t6q0yON6GK_EmsTUZkvEcCQwEwIwd0vFrOcZ0ppQcE-0SNBQ2caLaI6kky8FuzvE777Hg_t_v61dsg26G78bRocPyBWGe3KQUtjfIZuL-dI-JJf198Uknz-qrBIlny9ai38BeC3PTw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=microRNA-92a+promotes+CNS+autoimmunity+by+modulating+the+regulatory+and+inflammatory+T+cell+balance&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Fujiwara%2C+Mai&rft.au=Raheja%2C+Radhika&rft.au=Garo%2C+Lucien+P.&rft.au=Ajay%2C+Amrendra+K.&rft.date=2022-05-16&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.eissn=1558-8238&rft.volume=132&rft.issue=10&rft_id=info:doi/10.1172%2FJCI155693&rft_id=info%3Apmid%2F35298438&rft.externalDocID=PMC9106347
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-8238&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-8238&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-8238&client=summon